Geneos Wealth Management’s Cricut CRCT Stock Holding History

Geneos Wealth Management’s Portfolio CRCT Stock Details CRCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,000	Closed	-$6K	–	2119
2022 Q2	$6K	Hold	1,000	–	–	﹤0.01%	2124
2022 Q1	$13K	Buy	+1,000	New	+$17.3K	﹤0.01%	1965

Other funds holding CRCT

ACA

Abdiel Capital Advisors New York $52M AUM 13.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geneos Wealth Management's CRCT Position: Q3 2022 in Review

Geneos Wealth Management sold out of Cricut (CRCT) in Q3 2022, closing a stake of 1,000 shares — an estimated $6K sold.

Geneos Wealth Management first reported a position in CRCT in Q1 2022 and held it in 2 quarters. The position peaked at $13K in Q1 2022. 47 funds tracked by Wall St. Rank hold CRCT as of Q3 2022.

Geneos Wealth Management reported no remaining Cricut position as of Q3 2022 after selling out during the quarter.
Geneos Wealth Management sold 1,000 Cricut shares in Q3 2022, an estimated $6K.
Geneos Wealth Management first reported a position in Cricut in Q1 2022 and held it in 2 quarters.
Geneos Wealth Management's Cricut position peaked at $13K in Q1 2022.
47 funds tracked by Wall St. Rank held Cricut as of Q3 2022.

Based on Geneos Wealth Management's 13F filing for Q3 2022, filed 14 Nov 2022.